先健科技(01302.HK)中期營業額約6.5億元 同比增加約2.1%
格隆匯8月30日丨先健科技(01302.HK)公吿,截至2024年6月30日止6個月的營業額約為人民幣6.5億元,同比增加約2.1%;公司擁有人應占純利約為人民幣2.06億元;董事會不建議派付截至2024年6月30日止6個月的任何中期股息(2023年同期:無)。
中國內地仍是公司最大的市場,截至2024年6月30日止6個月,中國內地產生的收益佔總收益約75.1%(2023年同期:約80.4%)。同時,截至2024年6月30日止6個月,亞洲(不包括中國內地)及歐洲為公司最大的兩個海外市場,分別估總收益的約10.9%及10.0%(2023年同期:分別約8.5%及7.5%)。集團海外銷吿額較2023年同期增加約29.8%,這主要得益於公司積極拓展海外業務並採取有效的營銷策略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.